Abstract
Background: Non-Hodgkin's lymphomas (NHLs) comprise a group of malignancies that are heterogeneous in terms of presentation, natural history, and prognosis. Primary NHL of the vagina is rare in immunocompetent females. Because of the low incidence of these lymphomas, standard treatment has not been defined. Case: A 34-year-old female patient with a primary vaginal NHL stage IE, with diffuse large-cell B lineage, had an excellent response to cytotoxic chemotherapy (rituximab, doxorubicin, cyclophosphamide, vindesine, bleomycin, and prednisone) without surgery or radiotherapy. Results: After 2 years of follow-up, she did not have any recurrence. Conclusions: Conservative management, based on chemotherapy in primary genital lymphoma stages I-II may be the treatment of choice in patients who wish to preserve their fertility. (J GYNECOL SURG 28:1)
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
